DGAP-News: Immunic, Inc. / Key word(s): Conference/Study results Immunic to Present Preclinical Data for Vidofludimus Calcium at the 17th Congress of ECCO and Announces Blinded Baseline Characteristics
DGAP-News: Immunic, Inc. / Key word(s): Conference Immunic, Inc. to Participate in Investor and Scientific Conferences in February 08.02.2022 / 12:30 The issuer is solely responsible
DGAP-News: Immunic, Inc. / Key word(s): Conference Immunic, Inc. to Participate in Investor and Scientific Conferences in February 08.02.2022 / 12:30 The issuer is solely responsible for the content of this announcement. Immunic, Inc. to Participate in Investor and Scientific Conferences in Febr.
/PRNewswire/ Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at.
/PRNewswire/ Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at.